Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
Baxter
Moodys
Mallinckrodt
Express Scripts

Last Updated: October 20, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Silver nitrate

See Plans and Pricing

« Back to Dashboard

Development status for investigational drug Silver nitrate: Sponsors, patents, clinical trial progress

Silver nitrate is an investigational drug.

There have been 18 clinical trials for Silver nitrate. The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 2015.

The most common disease conditions in clinical trials are Granuloma, Pleural Effusion, Malignant, and Pleural Effusion. The leading clinical trial sponsors are Assiut University, The University of Hong Kong, and University of Iowa.

There are seventy-nine US patents protecting this investigational drug and five hundred and eighty-six international patents.

Recent Clinical Trials for Silver nitrate
TitleSponsorPhase
Efficacy of Intralesional MMR Vaccine,Intralesional Candidal Antigen&Topical Podophyllin in Treatment of Genital WartsAssiut UniversityPhase 3
A Prospective Evaluation of Non-Operative Treatments for Gastrocutaneous Fistulae in ChildrenDalhousie UniversityPhase 4
A Prospective Evaluation of Non-Operative Treatments for Gastrocutaneous Fistulae in ChildrenMontreal Children's Hospital of the MUHCPhase 4

See all Silver nitrate clinical trials

Clinical Trial Summary for Silver nitrate

Top disease conditions for Silver nitrate
Top clinical trial sponsors for Silver nitrate

See all Silver nitrate clinical trials

US Patents for Silver nitrate

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Silver nitrate   Start Trial Light-sensitive material containing silver halide, reducing agent, polymerizable compound and a fluorine atom-containing compound Fuji Photo Film Co., Ltd. (Kanagawa, JP)   Start Trial
Silver nitrate   Start Trial Light-sensitive material containing silver halide, reducing agent and polymerizable compound Fuji Photo Film Co., Ltd. (Kanagawa, JP)   Start Trial
Silver nitrate   Start Trial Light-sensitive material containing silver halide, reducing agent and polymerizable compound Fuji Photo Film Co., Ltd. (Kanagawa, JP)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Johnson and Johnson
Dow
Moodys
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.